Bioprinted tissues, developed through the collaboration between Aspect Biosystems and Novo Nordisk, offer a more accurate and efficient platform for drug testing and understanding obesity’s impact on human tissues.
Bioprinted tissues, developed through the collaboration between Aspect Biosystems and Novo Nordisk, offer a more accurate and efficient platform for drug testing and understanding obesity’s impact on human tissues. Bioprinted tissues provide realistic models for developing and testing new treatments, paving the way for more tailored and effective solutions in combating obesity.